A Potential Therapeutic Target for Steroid Resistant Asthma,” published in the December 2024 issue of Allergy and Immunology ...

These Tregs travel to the lung draining lymph nodes and protects the host from allergen-mediated allergic asthma by blocking Th2 cells.

Despite advances in the treatment of patients with the most severe forms of asthma, progress remains to ... that it is possible to specifically target Th2 lymphocytes, the main culprits of type ...

Having asthma, Hashimoto’s thyroiditis or atopic dermatitis in addition to alopecia areata raised the odds for early-onset, severe and prolonged alopecia areata, according to a research letter ...

Within the next year, KP-723 is expected to enter several Phase I trials in AD and may have applications in other Th2-mediated diseases, including asthma. 1 “To address the significant unmet need for ...

Gilead Sciences, Inc. (GILD) and LEO Pharma entered strategic partnership to develop and commercialize LEO Pharma's small molecule ...

This work sheds light on a new pathway controlling the functions of Th2 lymphocytes responsible for the deleterious immune response in the lungs of patients with type 2 asthma. They suggest that ...

Gilead Sciences Inc. and LEO Pharma have partnered to accelerate the development and commercialization of LEO Pharma’s small ...